62906-25-6Relevant articles and documents
Selective inhibition of bacterial and human topoisomerases by N-arylacyl O-sulfonated aminoglycoside derivatives
Fenner, Amanda M.,Oppegard, Lisa M.,Hiasa, Hiroshi,Kerns, Robert J.
supporting information, p. 470 - 474 (2013/07/11)
Numerous therapeutic applications have been proposed for molecules that bind heparin-binding proteins. Development of such compounds has primarily focused on optimizing the degree and orientation of anionic groups on a scaffold, but utility of these polya
